Endogenous peptide hormone / antidote
Pregnancy: Safe to use for severe hypoglycaemia in pregnancy.
Glucagon
Brand names: GlucaGen, Baqsimi (intranasal)
Adult dose
Dose: Hypoglycaemia: 1 mg IM/SC/IV; Beta-blocker/CCB overdose: 5–10 mg IV bolus, then 1–10 mg/hour infusion
Route: IM, SC, IV, or intranasal
Frequency: Single dose (hypoglycaemia); repeat if no response after 15 min
Max: 10 mg IV bolus (overdose protocol)
Severe hypoglycaemia (unable to swallow): 1 mg IM/SC immediately; repeat after 15 min if no response. Baqsimi: 3 mg intranasal single dose. Beta-blocker or CCB overdose: 5–10 mg IV bolus over 1 min, then continuous infusion matching bolus response rate.
Paediatric dose
Route: IM
Frequency: Single dose; repeat if needed
Max: 1 mg/dose
Concentration: 1 mg/ml
<25 kg: 0.5 mg IM. >25 kg: 1 mg IM. Baqsimi intranasal (≥4 years): 3 mg single dose. Neonatal hypoglycaemia: 0.2 mg/kg IM/SC (max 1 mg) — specialist guidance.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution in fasting states or hepatic failure (liver glycogen depleted — less effective).
Clinical pearls
- Glucagon requires hepatic glycogen stores — may be ineffective in prolonged fasting, alcohol-related hypoglycaemia, or liver disease
- Baqsimi nasal powder: lay patient on side (prevent aspiration from vomiting); works even if sniffing not optimal
- After glucagon for hypoglycaemia: follow with oral carbohydrate when conscious and swallowing safely
- Overdose protocol: high dose glucagon (5–10 mg IV) bypasses blocked beta-receptors — useful for severe beta-blocker or CCB toxicity
- Contact NPIS for complex beta-blocker/CCB overdose management
Contraindications
- Phaeochromocytoma (releases catecholamines)
- Insulinoma
- Glucagonoma
Side effects
- Nausea and vomiting
- Tachycardia
- Hypertension
- Hypokalaemia
- Hyperglycaemia (rebound)
Interactions
- Warfarin — may increase anticoagulant effect
Monitoring
- Blood glucose every 15 min
- HR and BP (overdose protocol)
- Level of consciousness
Reference: BNFc; BNF; JBDS Hypoglycaemia Guidelines; TOXBASE. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines